Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.

Research output: Contribution to journalArticle


B-cell disorders include a large group of malignant and nonmalignant diseases with tremendous variation in incidence, natural history, treatment, and prognosis. This article will focus on adult idiopathic thrombocytopenic purpura (ITP) and chronic lymphocytic leukemia (CLL). Clinicians must individualize treatment for ITP and CLL to each patient. Observation without intervention is appropriate for some patients, whereas immediate treatment is indicated for others. Deciding when to treat and which agents to use can be difficult, but new therapeutic options are emerging for both conditions.

Original languageEnglish (US)
Pages (from-to)23-36
Number of pages14
JournalClinical journal of oncology nursing
Issue number1 Suppl
StatePublished - Feb 1 2007


ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)

Cite this